`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`HOSPIRA, INC., and
`SAMSUNG BIOEPIS CO., LTD., 1
`Petitioners,
`v.
`
`GENENTECH, INC.,
`Patent Owner,
`____________
`Case IPR2017-01489
`Patent 6,407,213
`____________
`
`
`REPLY DECLARATION OF BENJAMIN A. LASKY
`
`
`
`
`1 Samsung Bioepis Co. Ltd.’s IPR2017-02140 has been joined with this proceeding.
`
`(IPR2017-02140, Paper 40)
`
`PFIZER and SAMSUNG v. GENENTECH
`IPR2017-01489
`PFIZER EX. 1704, Page 1
`
`
`
`
`
`I, Benjamin A. Lasky, declare under penalty of perjury as follows:
`I am an attorney and Partner of the law firm Kirkland & Ellis, LLP.
`1.
`
`2.
`
`I make this Declaration in support of Petitioners’ Reply to Patent
`
`Owner Genentech’s Response.
`
`3.
`
`Exhibit 1693 is a true and correct copy of Foote, Humanized
`
`Antibodies, 61(269) NOVA ACTA LEOPOLDINA 103–110 (1989).
`
`4.
`
`Exhibit 1694 is a true and correct copy of Kolbinger, et al.,
`
`Humunization of a Mouse Anti-Human IgE Antibody: A Potential Therapeutic for
`
`IgE-Mediated Allergies, 6(8) PROTEIN ENGINEERING 971–980 (1993).
`
`5.
`
`Exhibit 1695 is a true and correct copy of DAVID J. KING,
`
`APPLICATIONS AND ENGINEERING OF MONOCLONAL ANTIBODIES (1998).
`
`6.
`
`Exhibit 1696 is a true and correct copy of Presta, Humanized
`
`Monoclonal Antibodies, 29 ANN. REP. IN MED. CHEMISTRY, 317–324 (1994).
`
`7.
`
`Exhibit 1697 is a true and correct copy of Deposition Transcript of Ian
`
`A. Wilson, dated April 21, 2018.
`
`8.
`
`Exhibit 1698 is a true and correct copy of Deposition Transcript of
`
`Paul J. Carter, dated April 27, 2018.
`
`9.
`
`Exhibit 1699 is a true and correct copy of Deposition Transcript of
`
`Leonard G. Presta, dated May 1, 2018.
`
`2
`
`
`PFIZER and SAMSUNG v. GENENTECH
`IPR2017-01489
`PFIZER EX. 1704, Page 2
`
`
`
`
`
`10. Exhibit 1700 is a true and correct copy of Deposition Transcript of
`
`Irene Loeffler, dated May 1, 2018.
`
`11. Exhibit 1701 is a true and correct copy of Deposition Transcript of
`
`John B. Ridgway Brady, dated April 27, 2018.
`
`12. Exhibit 1706 is a true and correct copy of Foote & Winter, Antibody
`
`Framework Residues Affecting the Conformation of the Hypervariable Loops, 224
`
`J. MOLECULAR BIOLOGY 487–499 (1991).
`
`13. Exhibit 1707 is a true and correct copy of Hale et al., Remission
`
`Induction in Non-Hodgkin Lymphoma with Reshaped Human Monoclonal
`
`Antibody Campath-1H, 332 LANCET 1394–1399 (1988).
`
`14. Exhibit 1708 is a true and correct copy of Mathieson et al.,
`
`Monoclonal Antibody Therapy in Systemic Vasculitis, 323(4) NEW ENG. J. MED.
`
`250–254 (1990).
`
`15. Exhibit 1709 is a true and correct copy of Kyle et al., Humanized
`
`Monoclonal Antibody Treatment in Rheumatoid Arthritis, 18(11) J.
`
`RHEUMATOLOGY 1737–1738 (1991).
`
`16. Exhibit 1710 is a true and correct copy of Brown, Jr. et al., Anti-Tac-
`
`H, a Humanized Antibody to the Interleukin 2 Receptor Prolongs Primate Cardiac
`
`Allograft Survival, 88 PROC. NAT’L. ACAD. SCI. U.S. 2663–2667 (1991).
`
`3
`
`
`PFIZER and SAMSUNG v. GENENTECH
`IPR2017-01489
`PFIZER EX. 1704, Page 3
`
`
`
`
`
`17. Exhibit 1711 is a true and correct copy of Havrdova, et. al.,
`
`Alemtuzumab in the Treatment of Multiple Sclerosis: Key Clinical Trial Results
`
`and Considerations for Use, 8(1) THERAPEUTIC ADVANCES IN NEUROLOGICAL
`
`DISORDERS 31–45 (2015).
`
`18.
`
`I declare under penalty of perjury under the laws of the United States
`
`of America that all statements made herein of my own knowledge are true and that
`
`all statements made on information and belief are believed to be true; and further
`
`that these statements were made with the knowledge that willful false statements
`
`and the like so made are punishable by fine or imprisonment, or both, under
`
`Section 1001 of Title 18 of the United States Code.
`
`Executed on May 25, 2018, in New York, New York.
`
`
` /Benjamin A. Lasky/
`Benjamin A. Lasky
`
`4
`
`
`PFIZER and SAMSUNG v. GENENTECH
`IPR2017-01489
`PFIZER EX. 1704, Page 4
`
`